Brainomix, a global leader in AI-powered imaging solutions in stroke and lung fibrosis, has announced the appointment of Anna Griffin as Chief Financial Officer, filling a key leadership role within the company following its recent £14M Series C funding round.
Anna joins Brainomix from Mirada Medical, another successful Oxford-based medical imaging company, where she had worked for 15 years, progressing through a series of increasingly senior roles, including most recently as Chief Financial & Operations Officer. Anna has extensive global experience, having managed Finance and Operations in the UK, Europe and the US.
Read the full article here
